Table I.
Characteristics of Patients Included in the Two Cross‐Sectional Surveys (Before and After the Intervention Program)
| 1º Survey Before Intervention | 2º Survey After Intervention | P Value | |
|---|---|---|---|
| Number of patients | 2489 | 2168 | |
| Age (mean, (95% CI) | 69 (68.7–69.4) | 69.3 (68.9–69.7) | .29 |
| Sex (% male) (%, 95% CI) | 50.5 (48.6–52.5) | 51.5 (49.4–53.6) | .52 |
| BMI (mean, 95% CI) | 29.5 (29.3–29.7) | 29.3 (29.1–29.5) | .18 |
| Waist circumference (mean, 95% CI) | 99.6 (99–100.2) | 100 (93.3–100.6) | .41 |
| CV risk factorsa (mean, 95% CI) | 3.8 (3.7–3.8) | 3.7 (3.7–3.8) | .14 |
| Age (men >55 years; women >65 years) (%, 95% CI) | 80.0 (78.4–81.6) | 80.2 (78.5–81.9) | .85 |
| Dyslipidemia (%, 95% CI) | 75.8 (74.1–77.5) | 75.11 (73.3–77.0) | .61 |
| Abdominal obesity (%, 95% CI) | 63.4 (61.3–65.4) | 64.0 (61.7–66.2) | .69 |
| Diabetes mellitus (%, 95% CI) | 45.3 (43.4–47.3) | 44.4 (42.3–46.5) | .51 |
| Smoking (%, 95% CI) | 13.3 (11.9–14.7) | 13.1 (11.6–14.6) | .32 |
| Family history of premature CV disease (%, 95% CI) | 11.1 (9.86–12.3) | 9.9 (8.62–11.1) | .17 |
| Subclinical organ damagea (%, 95% CI) | 41.9 (39.9–43.8) | 38.8 (36.7–40.9) | .03 |
| Microalbuminuria | 28.4 (25.7–31.0) | 29.5 (26.5–32.4) | .57 |
| Left ventricular hypertrophy | 31.4 (29.5–33.3) | 27.67 (25.7–29.6) | .007 |
| Slight increase in plasma creatinine | 7.63 (6.5–8.7) | 6.71 (5.6–7.8) | .24 |
| Establish CV or renal disease (%, 95% CI) | 36.4 (34.4–38.4) | 35.0 (32.8–37.1) | .33 |
| Ischemic cardiopathy | 18.3 (16.6–19.9) | 16.3 (14.6–17.9) | .09 |
| Peripheral artery disease | 8.9 (7.7–10.0) | 8.5 (7.3–9.7) | .68 |
| Cerebrovascular disease | 7.4 (6.3–8.5) | 7.1 (5.9–8.2) | .63 |
| Renal diseasea | 6.1 (5.1–7.1) | 6.7 (5.6–7.8) | .45 |
| Advanced retinopathy | 2.2 (1.6–2.8) | 2.0 (1.4–2.6) | .60 |
Abbreviations: BMI, body mass index; CI, confidence interval; CV, cardiovascular.
aAccording to the European Society of Hypertension–European Society of Cardiology 2003 guidelines.19 Dyslipidemia: total cholesterol >250 mg/dL, or low‐density lipoprotein cholesterol >155 mg/dL, or high‐density lipoprotein cholesterol <40 mg/dL in men and <48 mg/dL in women. Abdominal obesity: abdominal circumference (men ≥102 cm; women ≥88 cm). Family history of premature CV disease (at <55 years in men, <65 years in women). Left ventricular hypertrophy: electrocardiogram: Sokolow‐Lyons >38 mm; Cornell >2440 mm/ms; echocardiogram: left ventricular mass index (men ≥125 g/m2; women ≥110 g/m2). Microalbuminuria: 30–300 mg/24 h; albumin‐creatinine ratio (men ≥22 mg/g; women ≥31 mg/g). Slight elevation of serum creatinine concentration: men 1.3–1.5 mg/dL; women 1.2–1.4 mg/dL). Renal disease: proteinuria (>300 mg/24 h); or serum creatinine (men >1.5 mg/dL; women >1.4 mg/dL).